Weight-loss pills threaten to reshape Britain’s consumer economy by LLB staff reporter August 17, 2026 August 17, 2026
AstraZeneca’s £300bn mega-merger talks signal new era of pharma consolidation by Thea Coates Finance Reporter August 3, 2026 August 3, 2026
GSK’s Cambridge move highlights the high cost of staying competitive by LLB staff reporter July 28, 2026 July 28, 2026
Cancer drug demand drives AstraZeneca growth by Amy Johnson LLB Finance Reporter July 27, 2026 July 27, 2026
AstraZeneca loses £20bn in value after major heart drug trial setback by Amy Johnson LLB Finance Reporter July 9, 2026 July 9, 2026
Novo Nordisk beats forecasts as Wegovy pill demand surges by Thea Coates Finance Reporter May 6, 2026 May 6, 2026
GSK to buy RAPT Therapeutics in $2.2 billion deal by LLB Finance Reporter January 20, 2026 January 20, 2026
Novo Nordisk Q1 results: ‘Strong performance’ and ‘rosy outlook’ expected by Thea Coates Finance Reporter May 2, 2024 May 2, 2024
Novo Nordisk’s record-breaking growth highlights ‘insatiable demand’ for weight loss drugs by LLB Finance Reporter February 1, 2024 February 1, 2024
Pfizer slumped by 36%, is it a good buy in 2024? by Thea Coates Finance Reporter January 25, 2024 January 25, 2024
